Further, the ex vivo confocal analysis of TNBC xenografts confirmed the higher EGFR targeting ability of 01_cysEGFR peptide than that of 06_cysEGFR peptide, as shown by the co-localization of peptides with the EGFR receptor expressed in tumor tissues. The gene discussed is EGFR; the disease is neoplasm.